Improving Clinical Trial Diversity Through Language-Inclusive Approaches: Daniel Virnich, MD

Daniel Virnich, MD, highlights the need for proactive social determinants of health screening, language-inclusive clinical trial practices, value-based treatment decisions, and policy reforms to improve equitable access to cancer care.